A Speech-Restoring Brain Implant has Won FDA Approval for Human Trials
Paradromics, a U.S. BCI startup, is emerging as a key neural tech contender after FDA approval for a human trial of its speech-restoration implant for people with paralysis. The Austin-based company, with multiple FDA Breakthrough Device designations, received IDE approval for its Connexus BCI Connect-One Early Feasibility Study. It is the first company to obtain […]
A Speech-Restoring Brain Implant has Won FDA Approval for Human Trials Read More »









